Vaccination of Immunocompromised Cats

Albert Lloret Roca, Katrin Hartmann, Karin Möstl, Etienne Thiry, Diane D. Addie, Sándor Belák, Corine Boucraut-Baralon, Herman Egberink, Tadeusz Frymus, Regina Hofmann-Lehmann, Hans Lutz, Fulvio Marsilio, Maria Grazia Pennisi, Séverine Tasker, Uwe Truyen, Margaret J. Hosie

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)


Immunocompromise is a common condition in cats, especially due to widespread infections with immunosuppressive viruses, such as feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV), but also due to chronic non-infectious diseases, such as tumours, diabetes mellitus, and chronic kidney disease, as well as treatment with immunosuppressive drugs, such as glucocorticoids, cyclosporins, or tumour chemotherapy. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from eleven European countries, discusses the current knowledge and rationale for vaccination of immunocompromised cats. So far, there are few data available on vaccination of immunocompromised cats, and sometimes studies produce controversial results. Thus, this guideline summarizes the available scientific studies and fills in the gaps with expert opinion, where scientific studies are missing. Ultimately, this review aims to help veterinarians with their decision-making in how best to vaccinate immunocompromised cats.
Original languageEnglish
Publication statusPublished - 2022


  • Feline
  • Immunocompromise
  • Immunosuppression
  • Immunodeficiency
  • Vaccine
  • Efficacy
  • Safety
  • Duration of immunity
  • DOI


Dive into the research topics of 'Vaccination of Immunocompromised Cats'. Together they form a unique fingerprint.

Cite this